Nisa Investment Advisors
CBMG

Nisa Investment Advisors’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Nisa Investment Advisors’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,175
Closed -$224K – 2335
2020
Q4 		$224K Buy
12,175
+8,060
+196% +$147K ﹤0.01% 1423
2020
Q3 		$75K Buy
+4,115
New +$69.2K ﹤0.01% 1647

Nisa Investment Advisors's CBMG Position: Q1 2021 in Review

Nisa Investment Advisors sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 12,175 shares — an estimated $224K sold.

Nisa Investment Advisors first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $224K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Nisa Investment Advisors reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 12,175 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $224K.
  • Nisa Investment Advisors first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Nisa Investment Advisors's Cellular Biomedicine Group, Inc. position peaked at $224K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Nisa Investment Advisors's 13F filing for Q1 2021, filed 26 Apr 2021.